Context Therapeutics Inc.

SEC 4 · Filed

0001628280-26-010616Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 19, 2026

Grant, award or other acquisition by Lehr Martin A.

Security
Stock Option (right to buy)
Code
A
Shares
815,000
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-19",
  "direction": "A",
  "exercise_price": "2.32",
  "expiration": "2036-02-18",
  "footnotes": {
    "F1": "The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."
  },
  "owners": [
    {
      "cik": "0001861989",
      "name": "Lehr Martin A.",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "815000",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "815000",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "815000"
}